165 related articles for article (PubMed ID: 25652250)
1. Effect of Brain CYP2B Inhibition on Brain Nicotine Levels and Nicotine Self-Administration.
Garcia KL; Coen K; Miksys S; Lê AD; Tyndale RF
Neuropsychopharmacology; 2015 Jul; 40(8):1910-8. PubMed ID: 25652250
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricularly and systemically delivered inhibitor of brain CYP2B (C8-Xanthate), even following chlorpyrifos exposure, reduces chlorpyrifos activation and toxicity in male rats.
Khokhar JY; Tyndale RF
Toxicol Sci; 2014 Jul; 140(1):49-60. PubMed ID: 24798379
[TBL] [Abstract][Full Text] [Related]
3. Brain CYP2B induction can decrease nicotine levels in the brain.
Garcia KLP; Lê AD; Tyndale RF
Addict Biol; 2017 Sep; 22(5):1257-1266. PubMed ID: 27230546
[TBL] [Abstract][Full Text] [Related]
4. Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects.
Khokhar JY; Tyndale RF
Neuropsychopharmacology; 2011 Feb; 36(3):692-700. PubMed ID: 21107310
[TBL] [Abstract][Full Text] [Related]
5. Nicotine self-administration, extinction responding and reinstatement in adolescent and adult male rats: evidence against a biological vulnerability to nicotine addiction during adolescence.
Shram MJ; Funk D; Li Z; Lê AD
Neuropsychopharmacology; 2008 Mar; 33(4):739-48. PubMed ID: 17507913
[TBL] [Abstract][Full Text] [Related]
6. Rat brain CYP2B induction by nicotine is persistent and does not involve nicotinic acetylcholine receptors.
Khokhar JY; Miksys SL; Tyndale RF
Brain Res; 2010 Aug; 1348():1-9. PubMed ID: 20599831
[TBL] [Abstract][Full Text] [Related]
7. mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats.
Dravolina OA; Zakharova ES; Shekunova EV; Zvartau EE; Danysz W; Bespalov AY
Neuropharmacology; 2007 Feb; 52(2):263-9. PubMed ID: 16963088
[TBL] [Abstract][Full Text] [Related]
8. A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats.
Boules M; Oliveros A; Liang Y; Williams K; Shaw A; Robinson J; Fredrickson P; Richelson E
Neuropeptides; 2011 Feb; 45(1):9-16. PubMed ID: 21047685
[TBL] [Abstract][Full Text] [Related]
9. Effect of infusion rate on intravenous nicotine self-administration in rats.
Wing VC; Shoaib M
Behav Pharmacol; 2013 Sep; 24(5-6):517-22. PubMed ID: 23907378
[TBL] [Abstract][Full Text] [Related]
10. Effect of menthol on nicotine intake and relapse vulnerability in a rat model of concurrent intravenous menthol/nicotine self-administration.
Nesil T; Narmeen S; Bakhti-Suroosh A; Lynch WJ
Psychopharmacology (Berl); 2019 Apr; 236(4):1219-1232. PubMed ID: 30483833
[TBL] [Abstract][Full Text] [Related]
11. Enhancing effect of menthol on nicotine self-administration in rats.
Biswas L; Harrison E; Gong Y; Avusula R; Lee J; Zhang M; Rousselle T; Lage J; Liu X
Psychopharmacology (Berl); 2016 Sep; 233(18):3417-27. PubMed ID: 27473365
[TBL] [Abstract][Full Text] [Related]
12. GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat.
Corrigall WA; Coen KM; Zhang J; Adamson KL
Psychopharmacology (Berl); 2001 Nov; 158(2):190-7. PubMed ID: 11702093
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of nicotine self-administration in adolescent rats given prolonged access to the drug.
Chen H; Matta SG; Sharp BM
Neuropsychopharmacology; 2007 Mar; 32(3):700-9. PubMed ID: 16794562
[TBL] [Abstract][Full Text] [Related]
14. SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
de Bruin NM; Lange JH; Kruse CG; Herremans AH; Schoffelmeer AN; van Drimmelen M; De Vries TJ
Behav Brain Res; 2011 Mar; 217(2):408-15. PubMed ID: 21074574
[TBL] [Abstract][Full Text] [Related]
15. Wistar Kyoto rats exhibit reduced sucrose pellet reinforcement behavior and intravenous nicotine self-administration.
De La Garza R
Pharmacol Biochem Behav; 2005 Oct; 82(2):330-7. PubMed ID: 16226802
[TBL] [Abstract][Full Text] [Related]
16. Substituted heteroaromatic compounds: effect on nicotine self-administration in rats.
Cashman JR; Okolotowicz K; Cerny M; Johnson R; Janowsky A; Azar MR
Psychopharmacology (Berl); 2012 Jun; 221(4):637-48. PubMed ID: 22218454
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glycine transporter 1 attenuates nicotine- but not food-induced cue-potentiated reinstatement for a response previously paired with sucrose.
Uslaner JM; Drott JT; Sharik SS; Theberge CR; Sur C; Zeng Z; Williams DL; Hutson PH
Behav Brain Res; 2010 Feb; 207(1):37-43. PubMed ID: 19799936
[TBL] [Abstract][Full Text] [Related]
18. Nicotine kinetics in zebra finches in vivo and in vitro.
Miksys S; Cappendijk SL; Perry WM; Zhao B; Tyndale RF
Drug Metab Dispos; 2013 Jun; 41(6):1240-6. PubMed ID: 23530019
[TBL] [Abstract][Full Text] [Related]
19. Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal.
Hall BJ; Pearson LS; Buccafusco JJ
Neuropharmacology; 2010 Feb; 58(2):429-35. PubMed ID: 19772864
[TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats.
Guillem K; Vouillac C; Azar MR; Parsons LH; Koob GF; Cador M; Stinus L
Eur J Neurosci; 2006 Dec; 24(12):3532-40. PubMed ID: 17229101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
